Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation
Authors
Keywords
-
Journal
BMJ Open Diabetes Research & Care
Volume 8, Issue 1, Pages e001238
Publisher
BMJ
Online
2020-05-25
DOI
10.1136/bmjdrc-2020-001238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010‐2017
- (2019) John M Dennis et al. DIABETES OBESITY & METABOLISM
- SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution
- (2019) Joseph I. Wolfsdorf et al. DIABETES CARE
- A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium‐glucose co‐transporter‐2 inhibitors
- (2019) Emily Brown et al. DIABETES OBESITY & METABOLISM
- Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes
- (2019) Iliana C. Lega et al. DIABETES OBESITY & METABOLISM
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus
- (2019) Maria Mirabelli et al. Journal of Diabetes Research
- Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017
- (2018) Helen J. Curtis et al. DIABETES OBESITY & METABOLISM
- Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
- (2018) John M. Dennis et al. DIABETES CARE
- Comparative risk of genital infections associated with SGLT2 inhibitors: A real-world retrospective cohort study
- (2018) Chintan V. Dave et al. DIABETES OBESITY & METABOLISM
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids
- (2018) Mohammed A Farhan et al. MEDICAL MYCOLOGY
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach
- (2018) John M. Dennis et al. Clinical Epidemiology
- Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes
- (2017) Lauren R Rodgers et al. BMJ Open
- Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study
- (2016) J. L. Hine et al. DIABETIC MEDICINE
- Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
- (2016) Jason H Y Wu et al. Lancet Diabetes & Endocrinology
- Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2016) Heidi Storgaard et al. PLoS One
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)
- (2015) Emily Herrett et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genital and urinary tract infections in diabetes: Impact of pharmacologically-induced glucosuria
- (2014) Suzanne Geerlings et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2013) EUROPEAN HEART JOURNAL
- Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin
- (2013) Kristina M. Johnsson et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Prevention of infection caused by immunosuppressive drugs in gastroenterology
- (2013) Katarzyna Orlicka et al. Therapeutic Advances in Chronic Disease
- Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
- (2009) B Komoroski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now